Mutation Profile of Resected EGFR‐Mutated Lung Adenocarcinoma by Next‐Generation Sequencing

BACKGROUND. The efficacy of adjuvant targeted therapy for operable lung cancer is still under debate. Comprehensive genetic profiling is needed for detecting co‐mutations in resected epidermal growth factor receptor (EGFR)‐mutated lung adenocarcinoma (ADC), which may interfere the efficacy of adjuva...

Full description

Saved in:
Bibliographic Details
Published in:Oncologist
Main Authors: Zhao, Ze‐Rui, Lin, Yao‐Bin, Ng, Calvin S.H., Zhang, Rong, Wu, Xue, Ou, Qiuxiang, Chen, Wendan, Zhou, Wen‐Jie, Lin, Yong‐Bin, Su, Xiao‐Dong, Shao, Yang W., Long, Hao
Format: Artigo
Language:Inglês
Published: John Wiley & Sons, Inc. 2019
Subjects:
Lung Cancer
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795151/
https://ncbi.nlm.nih.gov/pubmed/30872465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0567
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items